Drug-Induced Liver Disease - Neil Kaplowitz

Drug-Induced Liver Disease

(Autor)

Laurie D. DeLeve (Herausgeber)

Buch | Hardcover
830 Seiten
2007 | 2nd edition
Crc Press Inc (Verlag)
978-0-8493-9896-4 (ISBN)
329,95 inkl. MwSt
This book focuses on mechanisms of hepatotoxicity and reviews general principles of clinical presentation, histopathology, predisposition to toxicity, diagnosis, and management. It provides a systematic review of the major xenobiotics associated with drug-induced liver disease.
Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable reference for gastroenterologists, hepatologists, family physicians, internists, pathologists, pharmacists, pharmacologists, and clinical toxicologists, and graduate and medical school students in these disciplines. This book supplies an in-depth discussion of drug-induced hepatoxicology, covering mechanisms, histopathology, management, risk factors, and patterns of drug and toxin-induced disease. It includes contributions international experts.

Neil Kaplowitz, Laurie D. DeLeve

Part I: Mechanisms of Liver Injury 1. Drug-Induced Liver Disease 2. Cytochrome P450 Activation of Toxins and Hepatotoxicity 3. Antioxidant Defense in Liver Injury: Oxidant Stress, Antioxidant Defense, and Liver Injury 4. Hepatotoxicity Due to Mitochondrial Injury 5. Mechanisms of Cell Death and Relevance to Drug Hepatotoxicity 6. Significance of Hepatobiliary Transporters for Drug-Induced Liver Disease 7. Immunological Mechanisms in Drug-Induced Liver Injury 8. Mechanistic Role of Acyl Glucuronides 9. Nonparenchymal Cells, Inflammatory Macrophages, and Hepatotoxicity 10. Role of Tissue Repair in Liver Injury 11. Genetic Susceptibility to Drug-Induced Liver Disease Part II: Diagnosis and Management 12. Clinicopathological Patterns of Drug-Induced Liver Disease 13. Histopathology of Drug-Induced Liver Disease 14. Risk Factors for Drug-Induced Liver Disease 15. Genomics, Proteomics, and Metabolomics in the Diagnosis and Mechanisms of Drug-Induced Liver Disease 16. Causality Assessment 17. Management of the Patient with Drug-Induced Liver Disease Part III: Hepatotoxicity of Specific Drugs 18. Mechanisms of Acetaminophen-Induced Liver Disease 19. Acetaminophen: Pathology and Clinical Presentation of Hepatotoxicity 20. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Anti-inflammatory Drugs 21. Nonsteroidal Anti-inflammatory Drugs and Leukotriene Receptor Antagonists: Pathology and Clinical Presentation of Hepatotoxicity 22. Mechanism, Pathology, and Clinical Presentation of Hepatotoxicity of Anesthetic Agents 23. Anticonvulsant Agents 24. Hepatotoxicity of Psychotropic Drugs and Drugs of Abuse 25. Antibacterial and Antifungal Agents 26. Hepatotoxicity of Antituberculosis Drugs 27. Hepatic Toxicity of Antiviral Agents 28. Hepatotoxicity of Cardiovascular and Antidiabetic Medications 29. Cancer Chemotherapy 30. Hepatotoxicity of Immunomodulating Agents and the Transplant Situation 31. Methotrexate Controversies 32. Adverse Effects of Hormones and Hormone Antagonist

Erscheint lt. Verlag 10.7.2007
Verlagsort Bosa Roca
Sprache englisch
Maße 178 x 254 mm
Gewicht 1882 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hepatologie
ISBN-10 0-8493-9896-7 / 0849398967
ISBN-13 978-0-8493-9896-4 / 9780849398964
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Diagnostik, Differenzialdiagnostik, Therapieansätze

von Frank Fischbach; Katharina Fischbach

Buch (2016)
Thieme (Verlag)
101,00